Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability

PLoS One. 2014 Sep 26;9(9):e107642. doi: 10.1371/journal.pone.0107642. eCollection 2014.

Abstract

Background and purpose: Vascular calcification, recapitulating bone formation, has a profound impact on plaque stability. The aim of the present study was to determine the influence of bone-like vascular calcification (named osteoid metaplasia = OM) and of osteoprotegerin on plaque stability.

Methods: Tissue from carotid endarterectomies were analysed for the presence of calcification and signs of vulnerability according to AHA grading system. Osteoprotegerin (OPG), pericytes and endothelial cells were sought using immuno-histochemistry. Symptoms and preoperative imaging findings (CT-scan, MRI and Doppler-scan) were analyzed. Human pericytes were cultured to evaluate their ability to secrete OPG and to influence mineralization in the plaque.

Results: Seventy-three carotid plaques (49 asymptomatic and 24 symptomatic) were harvested. A significantly higher presence of OM (18.4% vs 0%, p<0.01), OPG (10.2% of ROI vs 3.4% of ROI, p<0.05) and pericytes (19% of ROI vs 3.8% of ROI, p<0.05) were noted in asymptomatic compared to symptomatic plaques. Consistently, circulating OPG levels were higher in the plasma of asymptomatic patients (3.2 ng/mL vs 2.5 ng/mL, p = 0.05). In vitro, human vascular pericytes secreted considerable amounts of OPG and underwent osteoblastic differentiation. Pericytes also inhibited the osteoclastic differentiation of CD14+ cells through their secretion of OPG.

Conclusions: OPG (intraplaque an plasmatic) and OM are associated with carotid plaque stability. Pericytes may be involved in the secretion of intraplaque OPG and in the formation of OM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD146 Antigen / metabolism
  • Carotid Stenosis / diagnosis
  • Carotid Stenosis / metabolism*
  • Carotid Stenosis / pathology*
  • Cell Differentiation
  • Humans
  • Metaplasia
  • Osteoblasts / cytology
  • Osteoblasts / metabolism
  • Osteoprotegerin / blood
  • Osteoprotegerin / metabolism*
  • Pericytes / cytology
  • Pericytes / metabolism*
  • Plaque, Atherosclerotic / metabolism*
  • Plaque, Atherosclerotic / pathology*
  • RANK Ligand / metabolism
  • Vascular Calcification*

Substances

  • CD146 Antigen
  • Osteoprotegerin
  • RANK Ligand

Grants and funding

This work has been funded by an ANR (Agence Nationale de Recherche) grant and by a PHRC (Programme Hospitalier de Recherche Clinique) Grand Ouest grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.